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The presence of metastatic nodes is a survival-limiting factor for patients with mouth tumors.
Objective: To evaluate the causes of treatment failure in carcinomas of the tongue and floor of the 
mouth due to staging.
Method: This study included 365 patients with squamous cell carcinoma of the mouth treated from 
1978 to 2007; 48 were staged as T1, 156 as T2, 98 as T3, and 63 as T4, of which 193 were pNo and 
172 pN+.
Results: Among the pN+ cases, 17/46 (36.9%) of the patients not treated with radiation therapy had 
relapsing tumors, against 46/126 (36.5 %) of the patients who underwent radiation therapy. Success 
rates in the group of subjects submitted to salvage procedures were 16/51 (31.3%) for pN0 patients 
and 3/77 (3.9%) for pN+ patients.
Conclusion: Salvage procedure success and survival rates are lower for pN+ patients; pN+ individuals 
also have more relapsing local disease.
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INTRODUCTION
Squamous cell carcinoma of the tongue is the most 
common tumor of the oral cavity, accounting for 25% to 
40% of the cases of mouth neoplasms. The oral tongue’s 
rich lymphatic network and musculature make it the site in 
the mouth most frequently associated with neck metastasis1.
Local recurrence still ranks as the most common 
shortcoming in the treatment of carcinomas of the mouth. 
However, the presence of metastatic nodes before the start 
of treatment is a major adverse prognostic factor, and cuts 
by approximately 50% the patient’s expected survival2,3. 
Recurrences are common, especially among patients with 
advanced disease - stages III and IV - and within the first 
two years after treatment. Despite the poor prognosis 
associated with metastatic disease, regional recurrence is 
uncommon in carcinomas of the upper aerodigestive tract4.
This study aimed to determine the causes of failure 
in the treatment of carcinomas of the tongue and floor of 
mouth due to staging.
METHOD
This study was approved by the Research Ethics 
Committee of the institution where it was held and given 
permit No. 071 /2000.
Patient charts of patients with squamous cell 
carcinoma of the tongue and floor of the mouth treated 
with surgery between January 1978 and December 2007 
in a reference tertiary care center were reviewed. Patients 
with asymptomatic disease and individuals followed for 
less than 12 months were excluded. A total of 365 patients 
were selected. In patients with stage I disease not submitted 
to elective neck dissection, only the second episode of 
recurrence occurred after neck surgery was considered 
as regional recurrence. Disease in another anatomic site 
or distant at least two centimeters from the original tumor 
was diagnosed as second primary tumor. Patients submitted 
to salvage procedures were deemed successfully treated 
when no evidence of new relapsing disease was found in 
their latest visit to the hospital. All patients were restaged 
according to the 2002 TNM staging system. The number of 
episodes of local, regional, and distant relapsing disease and 
second primary tumors were assessed based on primary 
tumor site, staging, and postoperative radiation therapy. 
Regional recurrence and the distance to the second primary 
tumor were considered separately.
Actuarial survival rates were calculated using the 
Kaplan-Meier curve and differences between groups by the 
log-rank test. The chi-square test was used for qualitative 
variables. Multivariate analysis used logistic regression. 
Statistical significance was attributed to differences with 
p < 0.05.
Table 1. Types of relapsing disease per pN stage.
Recurrence pN0 n = 193 pN+ n = 172
None 104 58
LR 28 43
RR 13 17
DR 4 11
LR + RR 10 17
LR + DR 1 3
LR + RR + DR 3 0
RR + DR 0 3
Second tumor 33 21
* 3 pN0 patients and 1 pN+ with a second tumor had had locoregional 
recurrence. LR: Local recurrence; RR: Regional recurrence; 
DR: Distance recurrence.
Table 2. Local (LR), regional (RR) and distance (RD) recurrence 
per pN stage.
pN0 n = 193 pN+ n = 172
LR 42 (21%) 63 (36%) p = 0.002
RR 26 (13%) 37 (21%) p = 0.05
DR 8 (4%) 14 (8%) p = 0.10
RESULTS
The floor of the mouth was the site of the primary 
tumor in 198 cases, followed by the tongue in 160 pa-
tients, and both sites in seven individuals. Patient mean 
age was 53 years (22 to 84 years). Forty-eight tumors 
were staged as T1; 156 were T2 tumors; 98 were T3; 
and 63 were T4. In terms of metastasis, 193 patients 
were pN0 and 172 were pN+. The types of recurrence 
are described in Tables 1 and 2. Postoperative radiation 
therapy was offered to 27 pN0 patients and 126 pN+ 
patients. Local recurrence was seen in 17/46 (36.9%) 
pN+ patients not treated with radiation therapy and in 
46/126 (36.5%) pN+ patients submitted to postoperative 
radiation therapy (p = 0.95).
Salvage procedures in cases of locoregional 
recurrence were successful in 16/51 (31.3%) pN0 patients 
and in 3/77 (3.9%) pN + subjects (p = 0.0001). Likewise, 
surgery for a second primary tumor was successful in 
13/29 (44.8%) salvageable pN0 patients and in 2/21 (9.9%) 
pN+ subjects (p = 0.01). Tumor recurrences according to 
T stage and multivariate analysis are shown in Table 3. In 
multivariate analysis, factors T and pN had the strongest 
correlations with local recurrence, with p-values of 0.0002 
and 0.02, respectively. Actuarial survival according to pN 
staging is shown in Figure 1.
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Another factor to impact survival was the lower 
rate of success of salvage procedures in patients with 
locoregional recurrences initially staged as pN+, possibly 
due to the presence of more disease and the greater use 
of postoperative radiation therapy in such cases7. Distant 
recurrence was probably underdiagnosed, as indicated 
by the low incidence of reported cases and the fact that 
additional diagnostic tests were not ordered for patients 
with unresectable locoregional tumors. Distant metastases 
are directly related to locoregional disease staging and the 
presence of recurrence8.
Despite the higher incidence of a second tumor in 
pN0 patients - possibly explained by the longer survival of 
subjects in this group and the consistent incidence rates of 
a second tumor with time - treatment success rates were 
higher for this group of individuals4,7. We believe that 
the greater number of second tumors in subjects without 
regional metastasis (pN0) may be explained by the natural 
barrier inherent to the history of oral neoplasms that 
prevent tumors from spreading to regional nodes. In the 
absence of lymph nodes, the second tumor occurs in the 
pharynx, esophagus, lungs or pancreas. The appearance of 
tumors in the pancreas is more frequent among long-term 
survivors. Regional metastases are consistent with more 
aggressive tumors in all involved sites and marked 
decreases in survival, despite the fact that regional control 
can be achieved in most cases3,4,9.
It has been demonstrated that in patients with 
HPV-positive tumors, variables associated with regional 
metastases play a much less important role in prognosis 
than in patients with HPV-negative tumors. Better 
survival among HPV-positive patients is due in part to 
improved locoregional control, presumably reflecting 
the disease’s greater sensitivity to radiation therapy and 
radiosensitization by cisplatin10.
CONCLUSION
Salvage procedure success and survival rates are 
lower for pN+ patients when compared to pN0 patients. 
Individuals staged as pN+ also have more relapsing local 
disease.
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